US Broker Ratings

Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating Its Robust ROE and Growth Potential

Medpace Holdings, Inc. (NASDAQ: MEDP), a key player in the healthcare sector, presents a compelling opportunity for investors focused on diagnostics and research. With its market capitalization standing at an..

Glaukos Corporation (GKOS) Investor Outlook: Analyzing the 29.88% Potential Upside Amidst Healthcare Innovation

For investors keen on the medical device sector, Glaukos Corporation (NYSE: GKOS) is a name that demands attention. As a leader in ophthalmic pharmaceuticals and medical technology, Glaukos’s innovative approach..

Revolution Medicines, Inc. (RVMD)

⚠️ No article content returned.

..

Regeneron Pharmaceuticals, Inc. (REGN): Valuation Insights and Analyst Consensus Point to 54% Upside Potential

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stands as a formidable player in the biotechnology sector, notable for its commitment to pioneering treatments for a wide range of diseases. With a market..

Globus Medical, Inc. (GMED) Stock Analysis: Why a 43.91% Potential Upside is Grabbing Investor Attention

Globus Medical, Inc. (NYSE: GMED), a leading player in the medical devices sector, is catching the eye of investors with a compelling 43.91% potential upside according to analyst ratings. Headquartered..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Revenue Growth Shines Amidst Analyst Caution

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector specializing in drug manufacturing, has carved a significant niche in the global pharmaceutical landscape. With a market..

HealthEquity, Inc. (HQY) Stock Analysis: Strong Buy Ratings Signal 11.82% Potential Upside

In the ever-evolving healthcare sector, HealthEquity, Inc. (NASDAQ: HQY) stands out by offering a suite of technology-enabled services that cater to the financial health management needs of both consumers and..

Amgen Inc. (AMGN) Stock Report: Navigating a 9% Potential Upside with Strong Revenue Growth

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, continues to capture the attention of individual investors with its robust pipeline and impressive revenue growth. With a market capitalization..

Stevanato Group S.p.A. (STVN) Stock Analysis: A Healthcare Innovator with a 23% Potential Upside

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, has captured investor attention with its strategic positioning in the medical instruments and supplies industry. Headquartered in Piombino..

Exelixis, Inc. (EXEL) Stock Analysis: Navigating Growth in the Biotech Space with Robust Revenue Momentum

Exelixis, Inc. (NASDAQ: EXEL), a stalwart in the biotechnology sector, presents a compelling case for investors seeking exposure to the healthcare industry. With a focus on oncology, Exelixis is at..

The Ensign Group, Inc. (ENSG) Stock Analysis: Exploring a 12.86% Upside Potential in the Healthcare Sector

The Ensign Group, Inc. (NASDAQ: ENSG), a significant player in the healthcare industry, has caught the attention of investors with its promising potential upside of 12.86%. With a market cap..

Insulet Corporation (PODD) Stock Analysis: A Healthcare Powerhouse with a 28.8% Revenue Growth

Insulet Corporation (NASDAQ: PODD) is making waves in the healthcare sector, particularly within the medical devices industry, thanks to its innovative insulin delivery systems. Based in Acton, Massachusetts, Insulet has..

Solventum Corporation (SOLV) Stock Analysis: Navigating a 12.42% Potential Upside

Solventum Corporation (NYSE: SOLV), a burgeoning player in the healthcare sector, is capturing the attention of investors with its promising potential upside of 12.42%. With a market capitalization of $12.65..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Exploring the 65.16% Potential Upside for Investors

BioMarin Pharmaceutical Inc. (BMRN), a stalwart in the biotechnology sector, presents a promising opportunity for investors seeking exposure to the healthcare industry. With a market capitalization of $11.14 billion, BioMarin..

ICON plc (ICLR) Stock Analysis: A 35% Upside Potential in the Healthcare Sector

ICON plc (NASDAQ: ICLR), a major player in the healthcare sector, specifically within the diagnostics and research industry, stands out as a compelling investment opportunity. Based in Dublin, Ireland, ICON..

Bristol-Myers Squibb (BMY) Stock Analysis: Unlocking a 17.98% Potential Upside with a Robust Dividend Yield

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, continues to be a compelling investment opportunity for individuals with a keen eye on both growth potential and income..

AptarGroup, Inc. (ATR) Investor Outlook: Examining a 10.48% Potential Upside

AptarGroup, Inc. (NYSE: ATR), a pioneering name in the medical instruments and supplies industry, is capturing attention for its potential upside of 10.48%. With a market cap of $10.46 billion,..

Royalty Pharma plc (RPRX) Stock Analysis: Exploring a 26% Upside Potential with Strong Buy Ratings

Royalty Pharma plc (NASDAQ: RPRX) stands as a unique player in the healthcare sector, specifically within the biotechnology industry. With a robust market capitalization of $18.49 billion, the company offers..

Baxter International Inc. (BAX) Stock Analysis: Exploring a 26% Potential Upside Amidst Healthcare Innovation

Investors eyeing opportunities in the healthcare sector may find Baxter International Inc. (NYSE: BAX) an intriguing option. With a market capitalization of $15.65 billion, this American stalwart in the medical..

Cigna Group (CI) Stock Analysis: A Healthcare Powerhouse with 18.5% Potential Upside

The Cigna Group (NYSE: CI), a prominent player in the healthcare plans industry, is attracting attention with its solid market position and promising financial metrics. With a robust market capitalization..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds